Investigating how HIV-1 integrase affects virus formation and targeting it with new drugs
Role of HIV-1 integrase in virion morphogenesis and its targeting by allosteric integrase inhibitors
This study is looking at how a part of the HIV virus called integrase helps the virus form and how new medications can block it, with the goal of finding better treatments for people living with tough-to-treat HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11020163 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of HIV-1 integrase in the formation of the virus and how it can be targeted by new types of medications called allosteric integrase inhibitors. The team is exploring how integrase interacts with the viral RNA to ensure the virus is properly formed and infectious. By studying these interactions, they aim to develop innovative treatments for patients with multi-drug resistant HIV-1. The research includes both laboratory experiments and clinical trials of promising new drugs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with multi-drug resistant HIV-1 who have not responded to standard treatments.
Not a fit: Patients who are not infected with HIV-1 or those with drug-sensitive strains of the virus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options for patients with drug-resistant HIV-1 infections.
How similar studies have performed: Previous research has shown promise in targeting integrase with novel inhibitors, indicating potential for success in this approach.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Kvaratskhelia, Mamuka — University of Colorado Denver
- Study coordinator: Kvaratskhelia, Mamuka
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.